Published in J Immunol on May 01, 2002
Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev (2006) 3.79
Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity (2008) 3.24
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol (2007) 3.18
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology (2005) 3.18
Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol (2009) 3.17
Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun (2003) 3.01
Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol (2012) 2.86
Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol (2004) 2.27
Granulomatous disease in common variable immunodeficiency. Clin Immunol (2009) 2.07
In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect Immun (2002) 1.88
Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. Lancet Infect Dis (2014) 1.86
TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest (2004) 1.76
Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infect Immun (2006) 1.74
Role of innate cytokines in mycobacterial infection. Mucosal Immunol (2011) 1.68
Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J Immunol (2009) 1.66
A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology (2008) 1.65
Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol (2007) 1.61
How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol (2010) 1.48
Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J Virol (2008) 1.48
Cytokine gene expression in peripheral blood mononuclear cells and tissues of cattle infected with Mycobacterium avium subsp. paratuberculosis: evidence for an inherent proinflammatory gene expression pattern. Infect Immun (2004) 1.45
Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med (2003) 1.45
Genome scan of M. tuberculosis infection and disease in Ugandans. PLoS One (2008) 1.41
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery. Vaccine (2012) 1.40
Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci U S A (2009) 1.38
Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut (2003) 1.38
Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun (2007) 1.34
Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation. J Immunol (2011) 1.32
Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf (2013) 1.31
Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis (2005) 1.31
Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue. PLoS Comput Biol (2007) 1.29
In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect Immun (2003) 1.25
Key issues in the diagnosis and management of tuberculosis. J R Soc Med (2007) 1.25
Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. Am J Pathol (2005) 1.21
Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease. Front Immunol (2013) 1.21
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis (2003) 1.20
TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. J Theor Biol (2010) 1.20
Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss. J Immunol (2012) 1.18
Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol (2012) 1.16
A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Microbiology (2008) 1.15
The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clin Dev Immunol (2012) 1.14
Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF. Ann Rheum Dis (2003) 1.14
Do RANKL inhibitors (denosumab) affect inflammation and immunity? Osteoporos Int (2010) 1.12
Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis. PLoS One (2012) 1.11
Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Sci Rep (2013) 1.10
NK cells and gamma interferon coordinate the formation and function of hepatic granulomas in mice infected with the Francisella tularensis live vaccine strain. Infect Immun (2008) 1.08
Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev (2014) 1.06
T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin Exp Immunol (2004) 1.06
Linkage and association analysis of candidate genes for TB and TNFalpha cytokine expression: evidence for association with IFNGR1, IL-10, and TNF receptor 1 genes. Hum Genet (2007) 1.04
Macrophages in tuberculosis: friend or foe. Semin Immunopathol (2013) 1.04
Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium? Front Microbiol (2011) 1.04
Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity. J Biol Chem (2012) 1.01
Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis. J Virol (2006) 1.00
Mathematical modeling of tuberculosis bacillary counts and cellular populations in the organs of infected mice. PLoS One (2010) 0.98
Cytokines in the balance of protection and pathology during mycobacterial infections. Adv Exp Med Biol (2013) 0.97
Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis (Edinb) (2007) 0.97
Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab. Clin Rheumatol (2006) 0.97
Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits. Infect Immun (2004) 0.97
Pleural tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomas. PLoS One (2009) 0.97
Chemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epithelium. J Neuroinflammation (2015) 0.96
NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis. Front Physiol (2012) 0.96
T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum. J Infect Dis (2005) 0.95
Modeling socio-demography to capture tuberculosis transmission dynamics in a low burden setting. J Theor Biol (2011) 0.95
Granuloma formation in pulmonary sarcoidosis. Front Immunol (2013) 0.93
Pulmonary mycobacterial granuloma increased IL-10 production contributes to establishing a symbiotic host-microbe microenvironment. Am J Pathol (2011) 0.93
Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol (2007) 0.91
Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis. Clin Dev Immunol (2012) 0.91
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis. Clin Exp Immunol (2005) 0.91
Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol (2005) 0.91
In situ IL-12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli. J Immunol (2009) 0.90
Risk of infections associated with biological treatment in inflammatory bowel disease. World J Gastroenterol (2014) 0.90
Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming. Genet Vaccines Ther (2007) 0.88
Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency. Clin Exp Immunol (2009) 0.88
Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection. Infect Immun (2005) 0.88
Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. Clin Infect Dis (2013) 0.88
Diverse cytokine profile from mesenteric lymph node cells of cull cows severely affected with Johne's disease. Clin Vaccine Immunol (2011) 0.87
DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice. Clin Vaccine Immunol (2006) 0.86
Mycobacterium avium subsp. paratuberculosis infection causes suppression of RANTES, monocyte chemoattractant protein 1, and tumor necrosis factor alpha expression in peripheral blood of experimentally infected cattle. Infect Immun (2003) 0.86
Region of difference 2 contributes to virulence of Mycobacterium tuberculosis. Infect Immun (2010) 0.86
Endocytosis of Mycobacterium tuberculosis heat shock protein 60 is required to induce interleukin-10 production in macrophages. J Biol Chem (2013) 0.86
Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-α reagents. Pediatr Rheumatol Online J (2014) 0.86
Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis. Clin Vaccine Immunol (2009) 0.85
M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression. BMC Microbiol (2006) 0.85
Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin Vaccine Immunol (2007) 0.85
Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS One (2012) 0.85
Role of PPE18 protein in intracellular survival and pathogenicity of Mycobacterium tuberculosis in mice. PLoS One (2012) 0.85
A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy. Clin Exp Med (2010) 0.85
Bactericidal function of alveolar macrophages in mechanically ventilated rabbits. Am J Respir Cell Mol Biol (2006) 0.84
Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis. J Clin Invest (2014) 0.84
Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection. Infect Immun (2005) 0.84
Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review. Infect Dis Ther (2013) 0.83
Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis. Clin Exp Immunol (2008) 0.83
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions. Clin Exp Immunol (2003) 0.83
Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance. Immunology (2007) 0.83
Mycobacterium tuberculosis Rv0652 stimulates production of tumour necrosis factor and monocytes chemoattractant protein-1 in macrophages through the Toll-like receptor 4 pathway. Immunology (2012) 0.83
Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis. Clin Vaccine Immunol (2009) 0.83
Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages. PLoS One (2010) 0.83
Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology. Tuberculosis (Edinb) (2011) 0.83
Lymphangiogenesis is induced by mycobacterial granulomas via vascular endothelial growth factor receptor-3 and supports systemic T-cell responses against mycobacterial antigen. Am J Pathol (2015) 0.82
Live Mycobacterium avium subsp. paratuberculosis and a killed-bacterium vaccine induce distinct subcutaneous granulomas, with unique cellular and cytokine profiles. Clin Vaccine Immunol (2008) 0.82
Immune subversion by Mycobacterium tuberculosis through CCR5 mediated signaling: involvement of IL-10. PLoS One (2014) 0.82
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med (2003) 5.97
Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe (2010) 3.39
Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J (2012) 2.99
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun (2006) 2.56
The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial. Am J Respir Crit Care Med (2011) 2.48
Life and death in the granuloma: immunopathology of tuberculosis. Immunol Cell Biol (2007) 2.46
ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol (2012) 1.99
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol (2005) 1.93
Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection. J Immunol (2009) 1.90
A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med (2006) 1.63
Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol (2002) 1.59
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med (2007) 1.48
A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem (2005) 1.47
Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol (2005) 1.44
Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev (2008) 1.42
A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol (2003) 1.36
Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization. Infect Immun (2002) 1.34
Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun (2010) 1.34
Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria. Nat Prod Rep (2008) 1.32
Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J Immunol (2006) 1.31
Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis (2008) 1.27
Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease. J Infect Dis (2009) 1.22
Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res (2004) 1.21
Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J Immunol (2009) 1.20
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. J Bacteriol (2006) 1.17
The Mycobacterium tuberculosis cysD and cysNC genes form a stress-induced operon that encodes a tri-functional sulfate-activating complex. Microbiology (2004) 1.15
Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect Immun (2006) 1.14
Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol (2006) 1.13
Antigen discovery: a postgenomic approach to leprosy diagnosis. Infect Immun (2006) 1.12
Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J Allergy Clin Immunol (2003) 1.12
Towards an immunodiagnostic test for leprosy. Microbes Infect (2006) 1.10
Characterization of chicken Mda5 activity: regulation of IFN-β in the absence of RIG-I functionality. J Immunol (2011) 1.09
Immune responses to dsRNA: implications for gene silencing technologies. Immunol Cell Biol (2005) 1.08
Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification. FASEB J (2009) 1.07
Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression. Proc Natl Acad Sci U S A (2011) 1.07
Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer. Microbes Infect (2006) 1.06
Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol (2009) 1.05
Single chain antibody fragments for the selective targeting of antigens to dendritic cells. Mol Immunol (2004) 1.04
Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation. J Clin Invest (2013) 1.04
A novel mycolactone toxin obtained by biosynthetic engineering. Chembiochem (2007) 1.02
Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. PLoS Pathog (2010) 1.02
Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis. Infect Immun (2002) 1.01
Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J Infect Dis (2005) 1.00
The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol (2003) 1.00
Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring. PLoS Negl Trop Dis (2011) 0.99
Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection. Vaccine (2005) 0.97
M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection. PLoS One (2012) 0.96
Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory. Eur J Immunol (2011) 0.96
Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper type 1 cytokine response in the chicken. J Interferon Cytokine Res (2011) 0.94
Molecular cloning, expression, and characterization of chicken IFN -lambda. J Interferon Cytokine Res (2008) 0.94
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J (2012) 0.93
Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine. J Infect Dis (2003) 0.93
Characterization of immune responses during infection with Mycobacterium avium strains 100, 101 and the recently sequenced 104. Immunol Cell Biol (2002) 0.93
Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg (2002) 0.92
Destabilized green fluorescent protein for monitoring transient changes in mycobacterial gene expression. Res Microbiol (2002) 0.91
Microparticles from mycobacteria-infected macrophages promote inflammation and cellular migration. J Immunol (2012) 0.91
In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen. Bioeng Bugs (2011) 0.91
Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis. Vaccine (2008) 0.91
Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection. Eur J Immunol (2010) 0.91
A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guérin immunisation in children and adults. PLoS One (2012) 0.89
Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads. Chem Commun (Camb) (2011) 0.89
Tetrahydrolipstatin inhibition, functional analyses, and three-dimensional structure of a lipase essential for mycobacterial viability. J Biol Chem (2010) 0.88
Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis. Immunol Cell Biol (2002) 0.87
Chicken interferons, their receptors and interferon-stimulated genes. Dev Comp Immunol (2013) 0.87
Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis. Infect Immun (2007) 0.87
Increased inducible nitric oxide synthase expression in organs is associated with a higher severity of H5N1 influenza virus infection. PLoS One (2011) 0.86
Total Synthesis of Teixobactin. Org Lett (2016) 0.86
Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis. Tuberculosis (Edinb) (2009) 0.86
Prebiotics modulate immune responses in the gut-associated lymphoid tissue of chickens. J Nutr (2009) 0.85
Epitope-tagging vectors for the expression and detection of recombinant proteins in mycobacteria. Plasmid (2005) 0.85
Interleukin-6 expression after infectious bronchitis virus infection in chickens. Viral Immunol (2007) 0.84
Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site. Org Biomol Chem (2012) 0.84
Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs. J Immunol (2007) 0.84
Ontogeny of the interferon system in chickens. J Reprod Immunol (2012) 0.83
Cytokines as adjuvants for avian vaccines. Immunol Cell Biol (2004) 0.83
LIGHT contributes to early but not late control of Mycobacterium tuberculosis infection. Int Immunol (2010) 0.82
The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection. Immunology (2003) 0.82
Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy. Am J Pathol (2009) 0.82
Comparison of IFN-gamma responses to mycobacterial antigens as markers of response to BCG vaccination. Tuberculosis (Edinb) (2008) 0.82
Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection. Infect Immun (2006) 0.81
Identification of strong promoter elements of Mycobacterium smegmatis and their utility for foreign gene expression in mycobacteria. FEMS Microbiol Lett (2003) 0.81
A diverted total synthesis of mycolactone analogues: an insight into Buruli ulcer toxins. Chemistry (2011) 0.81
Household contact investigation for tuberculosis in Vietnam: study protocol for a cluster randomized controlled trial. Trials (2013) 0.81
IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life. J Allergy Clin Immunol (2007) 0.80
Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens. Cell Mol Life Sci (2014) 0.80
Total synthesis of fellutamide B and deoxy-fellutamides B, C, and D. Mar Drugs (2013) 0.80
Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection. J Immunol (2013) 0.80
Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection. Infect Immun (2006) 0.80
Increasing the foreignness of an antigen, by coupling a second and foreign antigen to it, increases the T helper type 2 component of the immune response to the first antigen. Immunology (2005) 0.80
The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice. PLoS One (2012) 0.80
Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells. Exp Hematol (2007) 0.79
IFN-gamma enhances immune responses to E. coli infection in the chicken. J Interferon Cytokine Res (2007) 0.79